Imaging of integrin α(v)β(3) expression in patients with malignant glioma by [(18)F] Galacto-RGD positron emission tomography

Inhibitors targeting the integrin α(v)β(3) are promising new agents currently tested in clinical trials for supplemental therapy of glioblastoma multiforme (GBM). The aim of our study was to evaluate (18)F-labeled glycosylated Arg-Gly-Asp peptide ([(18)F]Galacto-RGD) PET for noninvasive imaging of α...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Schnell, Oliver, Krebs, Bjarne, Carlsen, Janette, Miederer, Isabelle, Goetz, Claudia, Goldbrunner, Roland H., Wester, Hans-Jürgen, Haubner, Roland, Pöpperl, Gabriele, Holtmannspötter, Markus, Kretzschmar, Hans A., Kessler, Horst, Tonn, Jörg-Christian, Schwaiger, Markus, Beer, Ambros J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Duke University Press 2009
Soggetti:
Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2802406/
https://ncbi.nlm.nih.gov/pubmed/19401596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2009-024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi